The total value of the cell surface marker detection market was USD 5,505.5 million in 2023, and it will touch USD 9,427.4 million by 2030, proceeding at a rate of 8.1 by the end of this decade. The industry is powered by the surge in the demand for precision medicine, increase in the acceptance of in vitro diagnostics, and tech progressions that enhance quantity and the rate of automation.
 |
| To learn more about this report: https://bit.ly/48GTZiF |
The flow cytometry category had the leading share, of 35%, in 2023. This is mostly because this method can measure a large count of parameters in the same sample and collect info from millions of cells within a few seconds. Moreover, with this method, any non-consistency in an unvarying cell population is sensed, and it also eliminates all the dead cells or wreckage when offering the final data.
Cell surface markers are prevailing tools that aid in identifying high-risk patients precisely, enhancing the accuracy of the analysis, proceeding follow-up policies for people, approximating susceptibility to targeted therapy or immunotherapy, and prediction of prognostic results.
North America led the pack with a share of 55%, in 2023, credited to the increasing number of tech progressions, surging elderly populace, and growing occurrence of chronic ailments.
The U.S. is facing a demographic shift with the surge in the count of citizens aged 65 and more. This age group’s share in the total people will rise to approximately 24 % by 2060 from 15% in 2016. The ageing populace is more prone to chronic ailments, for example cardiac ailments, gastrointestinal issues, and cancer. Moreover, the U.S. ranks 5th in the age-standardized rates for all cancers.
Due to the increasing demand for precision medicines all over the globe, the demand for cell surface marker detection is on the rise.
